The Rho-associated serine-threonine protein kinase (ROCK) is a downstream effector of Rho GTPases that is frequently activated in the epithelial to mesenchymal transition (EMT) of human ovarian cancer cells. On the other hand, endothelin-1 (ET-1) and its receptor endothelin A receptor (ET A R) are overexpressed in primary and metastatic ovarian carcinoma, which suggests that ET-1 promotes tumor dissemination. Hence, two human ovarian carcinoma cell lines, SK-OV-3 and CaOV3, were chosen to study the effects of ET-1/ET A R and ROCK in promoting EMT of ovarian cancer cells. We found that ET-1 exposure induced EMT of SK-OV-3 and CaOV3 by monitoring cells morphology, enhanced fibronectin, and reduced Ecadherin protein. At the same time, ET-1/ET A R enhanced the level of transcription of SLUG a transcriptional repressor of E-cadherin. More importantly, a constitutively active mutant of ROCK enhanced the transcription of SLUG by stimulating SLUG promoter activity. Furthermore, ROCK inhibitor Y27632 reversed the increase in fibronectin induced by ET-1/ ET A R. Our data suggest that ROCK cooperated with ET-1/ET A R to promote EMT of human ovarian carcinoma cells through upregulation of SLUG mRNA.
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Key words: Rho-associated serine threonine protein kinase; endothelin-1; endothelin A receptor; slug; epithelial to mesenchymal transition Epithelial ovarian carcinoma is a major cause of death in gynecological malignancy, 1) primarily due to a lack of methods of early detection. If progresses through rapid, aggressive, peritoneal dissemination of cells from the primary tumor. The molecular events that lead to the metastasis of ovarian tumor cells have not been well elucidated.
The epithelial to mesenchymal transition (EMT) is an essential morphologic conversion that occurs normally during embryonic development. Increasing evidence has given rise to the theory that a similar process occurs during cancer progression. This conversion confers a capacity on tumor cells to migrate, invade, and metastasize.
2) Endothelin-1 (ET-1) is a vasoactive peptide that has been implicated in the pathophysiology of a variety of human tumors.
3) ET-1 and its receptor, ET A R, are overexpressed in primary and metastatic ovarian carcinoma, and ET-1 is present at high levels in ovarian tumor ascites. 4) In ovarian tumor cells, it is an autocrine growth, survival, and angiogenic factor that selectively binds to the ET A R activating diverse signaling pathways. The ET-1/ET A R autocrine pathway drives EMT in tumor cells by inducing a fibroblastoid invasive phenotype. This phenotype is characterized by downregulation of an epithelial marker, E-cadherin, and upregulation of mesenchymal markers, including -catenin, a regulator of cell growth and adhesion, and Snail, a zinc finger transcription factor. In ovarian carcinoma xenografts, ABT-627, a small molecule ET A R antagonist, concomitantly suppressed both tumor growth and the expression of various angiogenic and invasive determinants involved in tumor progression. 5) It has been found that some members of the Rho family proteins are associated with a poor prognosis in bladder cancer. 6) Thus it is possible that changes in the activities of Rho GTPases within the cell can lead to invasion and metastasis. In confirmation of this, increased expression of Rho proteins has been found in tumors from the colon, breast, and lung. 7) A number of potential effector proteins have been identified that interact with members of the Rho family. These effector proteins are ultimately responsible for the diverse biological effects of Rho GTPases. 8) One of these downstream effectors is the Rho-associated serinethreonine protein kinase (ROCK). ROCK becomes activated when it binds selectively to the active, GTPbound form of Rho. The RhoA/ROCK signaling pathway has been found to be associated with the EMT of normal mammary gland epithelial cell 9) and it regulates actin cytoskeletal reorganization and the formation of focal adhesion. ROCK also plays an important role in cell migration. For example, it enhances cell contractility and is required for tail retraction in cancer cells.
But there have been no reports on the role of ROCK in the EMT of human ovarian cancer cells, and hence we observed its role in this study. Our results suggest that the tumorigenic activity of ROCK is associated with its ability to upregulate SLUG a transcriptional repressor of E-cadherin.
Materials and Methods
Cell culture. Two human ovarian carcinoma cell lines, SK-OV-3 and CaOV3, were obtained from the American Type Culture Collection (Manassas, VA). The cells were cultured in GIBCO Ò RPMI Media 1640 (Invitrogen, Carlsbad, CA), which contained 1% penicillin-streptomycin and 10% fetal calf serum (FCS) at 37 C under 5% CO2-95% air. Cells were counted in a hemocytometer, and their viability was 80-90% as assessed by trypan blue exclusion.
Immunofluorescence microscopy. SK-OV-3 and CaOV3 cells (1 Â 10 5 cells/well) were grown in RPMI 1640 containing 10% FBS on glass coverslips (22 Â 22 mm) for 24 h and then were grown without serum for overnight before treatment with and without 100 nM ET-1 for 24 h. Then the cells were fixed in methanol at À20 C for 20 min, blocked with 5% normal goat serum, and incubated with anti--tubulin (1:100). Then samples were washed twice with PBS and incubated with the appropriate Fluorescein Isothiocyanate (FITC)-conjugated secondary antibody. Negative controls were treated with nonspecific control IgG instead of a primary antibody. Coverslips were mounted on glass slides with fluorescence mounting medium and viewed with a Nikon Eclipse E600 fluorescence microscope.
Matrigel invasion assay. In vitro invasion was assayed by determining the ability of the cells to migrate through Matrigel, as previously reported. Protein extraction and Western blot analysis. Protocol 1: SK-OV-3 and CaOV3 cells were incubated for 24 h without serum, and then were incubated with and without 100 nM ET-1 for 24 h. The cell proteins were extracted with RIPA lysis buffer (Pierce Biotechnology, Rockford, IL), and then E-cadherin and fibronectin protein were detected by Western blot. Protocol 2: CaOV3 cells (3 Â 10 5 /well) were plated in RPMI 1640/0.5%FBS in 6-well plates with 100 nM ET-1 for 24 h in the presence of ROCK inhibitor Y27632 (LY), or after transfection with a constitutively active mutant of ROCK (ÁN), or without LY or ÁN. Cells without ET-1 were the control. Cell proteins were extracted with RIPA lysis buffer (Pierce Biotechnology) and then ROCK and fibronectin protein were detected by Western blot. Total protein (20 mg) was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto a nitrocellulose membrane. The membrane was incubated with antibodies specific for fibronectin (Santa Cruz Biotechnology, Santa Cruz, CA) (1:1,000), and ROCK (Santa Cruz Biotechnology) (1:1,000), or E-cadherin (Zymed, San Francisco, CA) (1:1,000), and -actin (Santa Cruz Biotechnology) (1:1,000). After overnight incubation at 4 C, antibodies were detected by adding anti-IgG conjugated with peroxidase and development with an enhanced chemiluminescence kit (Amersham Pharmacia Biotech, Piscataway, NJ).
RNA extraction and real-time RT-PCR. Protocol 1: SK-OV-3 and CaOV3 cells (3 Â 10 5 /well) were incubated in 6-well plates for 24 h without serum in RPMI 1640, and then were incubated with 100 nM ET-1 in RPMI 1640 for 0, 3, 6, 12, or 24 h, and then they were harvested to detect transcription of SLUG, Snail, and Twist; Protocol 2: SK-OV-3 and CaOV3 cells (3 Â 10 5 /well) were incubated in 6-well plates for 24 h without serum in RPMI 1640, and then were incubated with and without 100 nM ET-1 in RPMI 1640 in the presence or absence of BQ123 (1 mM) for 24 h. Then they were harvested to detect the transcription of SLUG; Protocol 3: SK-OV-3 and CaOV3 cells (3 Â 10 5 /well) were incubated in 6-well plates for 24 h without serum in RPMI 1640 and then transfected with constitutively active mutant of ROCK for the indicated durations. They were harvested to detect the transcription of SLUG and E-cadherin. The total RNA of the cells was extracted with TRIZOL reagent (Gibco-BRL, Gaithersburg, MD). Total RNA was then reverse transcribed with reverse transcriptase (Invitrogen, Carlsbad, CA) and the oligo dT primer to generate first-strand cDNA. PCR was then performed for 30 0 ; E-cadherin, sense 5 0 -AGAATGACAACAA-GCCCGAAT-3 0 and antisense 5 0 -CGGCATTGTAGGTGTTCACA-3 0 . Real-time RT-PCR was performed on the ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Foster City, CA). The SYBRGreen method was used for real-time PCR by a previous method.
11)
All quantification was normalized to an endogenous control GAPDH PCR product.
Reporter gene assays. SK-OV-3 and CaOV3 cells (3 Â 10
5 /well) were plated in RPMI 1640 with 10% FBS in 6-well plates for 24 h, then incubated with RPMI 1640 without serum overnight, and then transiently transfected with 1.5 mg of the SLUG promoter-pGL3 construct together with 15 ng of the renilla plasmid (Promega, Madison, WI). The cells were either contransfected with constitutively active ROCK ÁN, 12) (kindly provided by Professor Chen C.S., Department of Bioengineering, University of Pennsylvania) or incubated in the presence of ROCK inhibitor Y-27632. As a ROCK, p160ROCK is a target for Y-27632, Y-27632 should be useful in investigating the role of p160ROCK in these processes. 13 ) At 24 h after transfection, luciferase activities were assayed with a Luciferase Reporter Assay Kit (Promega) following the manufacturer's protocol. Luciferase units were calculated as luciferase activity/renilla activity. The results are presented as mean AE SD for three independent experiments, each performed in triplicate.
Statistical analysis. All results were expressed as mean AE SD. Statistical analysis of the data was performed by one-way ANOVA followed by Fisher's LSD Halics comparison using SPSS 12.0 software (SPSS, Boston, MA). A p value of <0:05 was considered statistically significant.
Results

ET-1 exposure induced morphologic and genetic changes consistent with EMT
First we performed confocal microscopy to determine whether ET-1 affects the morphology of CaOV3 and SK-OV-3 cells, which express high affinity ET A Rs. 14) CaOV3 and SK-OV-3 cells were incubated with 100 nM ET-1 for about 24 h. By that time, they had lost their epithelial cell morphology and had assumed a fibroblastlike appearance. These changes are typical of cells with a mesenchymal phenotype (Fig. 1A) . The Boyden Chamber invasion assay results suggest that ET-1 exposure enhanced cell invasive capacity, compared to control cells (Fig. 1B) .
Next we assessed to determine whether ET-1 exposure affects EMT protein expression. Cells incubated with 100 nM ET-1 for 24 h were assayed for expression of E-cadherin and fibronectin by Western blot. After 24 h of ET-1 stimulation, fibronectin, a mesenchymal marker, increased to 3-fold above control levels (Fig. 1C) . In addition, E-cadherin, an epithelial marker, decreased. Together, these results suggest that ET-1 stimulation of ET A R affected the expression of the genes involved in EMT and induced EMT-like morphological changes.
ET-1 induced transcription of SLUG
We performed quantitative real time PCR to determine whether E-cadherin repressors SLUG, Twist, and Snail might play roles in ET-1-induced EMT in CaOV3 and SK-OV-3 cells. As shown in Fig. 2A and B, after 24 h of ET-1 stimulation, SLUG mRNA levels increased, but Snail mRNA levels remained unchanged, and Twist mRNA levels decreased. We also observed that the increase in SLUG mRNA stimulated by ET-1 was completely blocked by incubation with ET A R antagonist BQ123 (Fig. 2C and D) . These results indicate that among the three E-cadherin transcriptional repressors, SLUG was the only one that responded to stimulation of the ET-1/ET A R axis.
ROCK was associated with ET-1/ET A R induced SLUG expression and EMT
Next we investigated to determine whether ET-1-induced SLUG expression was mediated by ROCK in CaOV3 and SK-OV-3 cells. We used Western blot analysis to detect ROCK protein expression after ET-1 treatment. ET-1 treated cells were either cultured with ROCK inhibitor Y27632 or co-transfected with the constitutively active construct ROCK. As shown in Fig. 3A and B, ROCK protein expression was low in the control cells. After exposure to ET-1, ROCK protein levels increased markedly. When cells grew in the medium with ET-1 and Y27632, the ROCK protein was present in lesser amounts as compared with the cells treated with ET-1. When cells were exposed to ET-1 after transfection with ROCK ÁN, ROCK protein expression increased markedly as compared with the normal control. To determine whether the molecular alterations associated with EMT had occurred in these cells, we examined the expression of the mesenchymal marker by Western blotting. As shown in Fig. 3A and B, ET-1 and ROCK ÁN increased the expression of fibronectin, a mesenchymal marker, which was strongly induced. To confirm further the role of ROCK in EMT, we inhibited ROCK with Y27632, and observed that ET-1 didn't increase the expression of fibronectin. Next we detected the invasion ability of different groups. As shown in Fig. 3C , under ET-1 treatment, invasion ability increased obviously and was stronger when ET-1 worked with ROCK ÁN. Together, these data indicate that ROCK plays a critical role in induction of the EMT of CaOV3 and SK-OV-3 cells.
ROCK increased SLUG mRNA synthesis by modulation of transcription and inhibited E-cadherin mRNA synthesis
Given the association of ROCK with the invasive phenotype, we reasoned that it might be important in activating the SLUG gene at the transcriptional level. As shown in Fig. 4A and B, real-time PCR analysis revealed that 24 h after ROCK ÁN transfection, an increase in SLUG mRNA occurred, and reached a peak at 48 h. At the same time, the level of E-cadherin mRNA fell.
To determine whether the SLUG gene is a downstream target of ROCK, CaOV3 and SK-OV-3 cells were transiently co-transfected with constitutively active ROCK and a reporter construct that encodes the human SLUG promoter sequence upstream of the gene that encodes luciferase. ROCK activation induced a 2.5-fold increase in SLUG promoter activity (Fig. 4C) . Inhibition of ROCK activity by Y27632 significantly decreased SLUG promoter activity. These results indicate that ROCK increases the transcription of SLUG by stimulating SLUG promoter activity.
Discussion
EMT is a critical cellular mechanism involved in tumor progression and metastasis, and it enhances cell motility and invasion. In this study, we made several findings: First, ET-1 bound to ET A R and then induced key events in EMT, including downregulation of Ecadherin (an epithelial marker), enhanced fibronectin (a mesenchymal marker), and enhanced cell invasiveness. About 80% of ovarian carcinomas are epithelial in origin. They are believed to arise through transformation of the ovarian surface epithelium. They are also known to be highly aggressive and invasive. When epithelial tumors acquire an invasive phenotype, they can be regarded as a pathological version of EMT. Functional loss of E-cadherin has been identified as a key step in the acquisition of invasive activity in EMT. The absence of E-cadherin also results in a total loss of epithelial cell polarity. A loss of E-cadherin expression can be caused by somatic mutations, chromosomal deletions, proteolytic cleavage, or silencing of the epithelial cadherin gene (CDH1) promoter. 16) CDH1 silencing can occur either by DNA hypermethylation or through the action of transcription factors, such as SLUG, Snail, and Twist, [17] [18] [19] which interact with the proximal E-boxes of the E-cadherin promoter. Snail and SLUG are zinc finger proteins that belong to the Snail superfamily. 20) Snail and SLUG have been detected at the sites of EMT in vertebrates. Ectopic expression of Snail and SLUG in epithelial cells caused EMT by causing migratory and invasive behavior similar to that evident in ovarian cancer. 21) In our study, ET-1/ET A R induced EMT in human ovarian cancer cells accompanied by increases in SLUG mRNA, but Snail mRNA was unchanged. Although SLUG and Snail are transcription factors of the same family, their effect in vivo can be modulated by their relative concentrations as well as by specific cellular or tumor contexts. 17) Twist has been found to be expressed at high levels in a number of human tumors. 22, 23) Importantly, increased Twist expression is associated with breast cancer metastasis to the lung, increased EMT, and intravasation. In the present study, in ovarian cancer cells, we found that Twist mRNA decreased in the EMT process induced by ET-1 treatment. This finding contradictes other findings. This suggests that repression factors act alone or in concert, and they may have different functions depending on the tumor type. Additional studies determine the roles of other mechanisms, such as mutations, posttranslational modifications, and transcriptional repression in the modulation of Twist in ovarian tumors.
The Rho/ROCK signaling pathway has been found to be involved in the motility and invasion of various cancer cell lines, including rat hepatoma cells, 24) human glioma cells, 25) and human ovarian cancer cells. 26, 27) Studies on clinical specimens have revealed a relationship between the expression levels of RhoC, an isoform of Rho, and tumor aggressiveness in breast cancer 28) and pancreatic cancer. 29) Taken together, these data indicate that Rho/ROCK signaling is associated with migration and invasion. In the present study, ET-1-induced SLUG protein expression was reversed by ROCK inhibitor A and B, Cells were transfected with a constitutively active mutant of ROCK for the indicated durations. Total RNA was extracted, and realtime PCR was performed with sequence-specific primers for SLUG and E-cadherin. GAPDH was included as internal control. Data are means AE SD, N ¼ 3.
Ã p < 0:05 as compared to transfection at 0 h. # p < 0:001 when compared to the transfection at 0 h. ÃÃ p < 0:01 as compared to transfection at 0 h. C, Cells were transfected with 1.5 mg of a SLUG promoter construct and 15 ng of renilla plasmid. 24 h after transfection, the cells were treated with 100 nM ET-1 for a further 24 h, with and without ROCK inhibitor Y27632 (LY). Alternatively, cells were treated with ET-1 after transfection with a constitutively active mutant of ROCK (ÁN). Both luciferase and renilla activity were assayed, and luciferase activity was normalized by renilla activity. GAPDH was included as internal control. Data are means AE SD, N ¼ 3.
ÃÃ p < 0:05 as compared to transfection with ÁN. ROCK worked with ET-1 to increase SLUG expression. Furthermore, we observed that ROCK increased transcription of the SLUG gene by stimulating SLUG promoter activity. These results indicate that ROCK is a critical regulator of EMT. Moreover, they are consistent with the observation that EMT-associated proteins, Ecadherin and fibronectin, can be modulated by ROCK inhibitors or activators. SLUG-mediated repression of E-cadherin has been reported. 30) SLUG also induced the expression of some mesenchymal genes, fibronectin. 31) Thus the identification of SLUG as a novel target of ROCK is relevant to understanding EMT mechanisms.
In summary, the results of this study reveal a new mechanism by which ROCK might promote the aggressive behavior of ovarian carcinoma cells. This mechanism involves ROCK-mediated upregulation of SLUG. These data highlight the importance of ROCK as a potential therapeutic target. Inhibition of ROCK might be a useful strategy for impeding ovarian cancer cell invasion and metastasis.
